Xilio Therapeutics, Inc.
XLONASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $175.03M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.64$10.42
- Volume (live)
- -
- Avg. volume (3M)
- 10.47K
Xilio Therapeutics (XLO) Stock Price & Financial Analysis
Xilio Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.55 - $9.00 |
|---|---|
| 52-Week High | $10.42 |
| 52-Week Low | $0.64 |
| Open | $8.91 |
| Volume (last close) | 29.60K |
| Average Volume (3M) | 10.47K |
| Revenue (TTM) | 64.09M |
|---|---|
| Net Income (TTM) | -21.83M |
| Free Cash Flow (TTM) | -61.27M |
| EPS (TTM) | −$1.48 |
| Profit Margin | -34.06% |
| Operating Margin | -48.94% |
| Return on Equity (ROE) | -30.21% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 175.03M |
|---|---|
| Shares Outstanding | 19.40M |
| Price to Sales (P/S) | 2.73 |
| Price to Book (P/B) | 2.42 |
| EV/EBITDA | -1.14 |
| 50-Day MA | $9.07 |
|---|---|
| 200-Day MA | $8.57 |
| 1-Year Change | +1113.67% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Xilio Therapeutics at a Glance
As of the Oct 16, 2026 close, Xilio Therapeutics (XLO) has a market capitalization of $175.03M. The stock trades at 2.7× sales. Over the trailing twelve months it lost $21.83M on revenue of $64.09M and burned $61.27M of free cash flow. Revenue grew 327.3% year over year.
As of its latest reported balance sheet, it holds $136.04M in cash and securities against $6.30M of debt, a net cash position of $129.74M.
Xilio Therapeutics does not currently pay a dividend.
The share price is up 1113.7% over the past year. At $8.55 (the Oct 16, 2026 close) it sits within its 52-week range of $0.64 to $10.42, below its 200-day moving average of $8.57.
Frequently Asked Questions About Xilio Therapeutics
What is the current stock price for XLO?
As of the Oct 16, 2026 close, XLO stock trades at $8.55. The 52-week range is $0.64–$10.42, with a day range of $8.55–$9.00.
What is the P/E ratio for XLO?
The P/E ratio (Price-to-Earnings) for XLO is shown in the Key Statistics section. This valuation metric helps compare Xilio Therapeutics, Inc. to industry peers.
Does XLO pay dividends?
Xilio Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for XLO?
Analyst ratings and recommendations for XLO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of XLO?
As of the Oct 16, 2026 close, Xilio Therapeutics's market capitalization is $165.9M, classifying it as a micro-cap company. Xilio Therapeutics operates in the Healthcare sector within the Biotechnology industry.